Cleveland Clinic News Service | 216.444.0141
We’re available to shoot custom interviews & b-roll for media outlets upon request.
CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.
images: 0
video: 0
audio: 0
text: 0
Cleveland Clinic’s Glickman Urological & Kidney Institute, which is ranked second in the nation for urology and nephrology, has received $2 million from Eugene and Zara Shvidler in support of nephrology and hypertension research. Their gift establishes The Shvidler Endowed Chair in Nephrology and Hypertension Research, which will be used to support current and future research projects at Cleveland Clinic.
The first chair holder is Michael Lioudis, MD, of Glickman’s Department of Nephrology and Hypertension. Dr. Lioudis’ specialties include hemodialysis, chronic kidney disease, resistant hypertension and renal diseases.
“I commend Dr. Lioudis for his efforts in making the endowed chair a reality,” says Rob Heyka, MD, Chair of the Department of Nephrology and Hypertension. “I also congratulate Mr. Shvidler for his insight and interest in these important medical problems. The endowed chair will allow us to support research to investigate critical issues in hypertension and kidney disease and have a significant impact on the care of patients.”
Toby Cosgrove, MD, CEO and President of Cleveland Clinic, says, “We are tremendously grateful to Eugene and Zara Shvidler for their support. Gifts such as theirs provide the flexibility to invest in and develop leading-edge initiatives and technology that benefit patients around the world.”
Endowed chairs allow chair holders to start new projects, support additional staff, pay for equipment and cover the cost of experiments, and they are incentives in recruiting and retaining top researchers. They are a tribute to the fine work of Cleveland Clinic physicians and researchers.
Endowed chairs also support the collection of preliminary data by chair holders, an important step in obtaining new outside funding. The endowment revenue also may support investigations into which patients will benefit most from new treatment approaches.
“I am greatly appreciative of Mr. Shvidler’s generous endowment to the Cleveland Clinic,” Dr. Lioudis says. “Mr. Shvidler has a vision of improving the health of individuals all around the world, and we will use this chair to fulfill this mission.”
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 81,000 employees worldwide are more than 5,743 salaried physicians and researchers, and 20,160 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,690-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 276 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2023, there were 13.7 million outpatient encounters, 323,000 hospital admissions and observations, and 301,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 132 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/CleClinicNews. News and resources available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
